clé de peau BEAUTÉ SYNACTIF EYE CREAM N 20g
clé de peau BEAUTÉ SYNACTIF EYE CREAM N 20g
  • Load image into Gallery viewer, clé de peau BEAUTÉ SYNACTIF EYE CREAM N 20g
  • Load image into Gallery viewer, clé de peau BEAUTÉ SYNACTIF EYE CREAM N 20g

clé de peau BEAUTÉ SYNACTIF EYE CREAM N 20g

Regular price
¥53,312
Sale price
¥53,312
Regular price
Sold out
Unit price
per 
Shipping calculated at checkout.

Made in JAPAN
20g

Renewed on February 21, 2021

EYE CREAM N (CRÈME YEUX N)

Powerfully boosts resilience for more youthful definition.

DESCRIPTION
An advanced formula that delivers the feeling of rapid, deep absorption with a lightweight texture for the delicate eye area.

The updated formula features a high concentration of Purifying Beautifier to holistically improve skin texture and tone. Also includes an intensive brightening ingredient to help prevent dullness, while Retinol ACE helps to improve the appearance of wrinkles.

Immediately, delicate eye-area skin is intensively rehydrated. Gives a plumped effect with a well-rested-looking glow. Day-by-day, the appearance of wrinkles becomes less visible. Eye-area skin achieves both newfound smoothness and a 'lifted' look. With continued use, the eye area looks dramatically redefined and beautiful from every angle.

HOW TO USE
Morning: apply to the eye area prior to SYNACTIF DAYTIME MOISTURIZER.
Evening: apply to the eye area after SYNACTIF CREAM N.
Use one pump in total. Dot onto eyelids and under each eye, smoothing in gently with fingertips.
Glide over the contours 1 and 2. Use the tips of the middle and ring fingers of both hands. Perform three times.

Inner eye corners → upper eyelid → front of ears
Inner eye corners → lower eyelid → front of ears

 

[Quasi-drugs]

Cosmetics and quasi-drugs categories
In Japan, the Japanese Ministry of Health, Labour & Welfare classifies the beauty products under 2 categories: cosmetics and quasi-drugs. Quasi-drugs, in opposite to cosmetics, are medicated, have a mild pharmacologic effect and include active ingredients. If the product is approved as a quasi-drug by the ministry, the manufacturer is allowed to actually claim the effectiveness of the product.